This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here

United Kingdom - English

United Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.

Chronic Anal Fissure

Find out about RECTOGESIC (glyceryl trinitrate 4mg/g Rectal Ointment), the ONLY treatment licensed in the UK for relief of pain associated with chronic anal fissure,^1,2 relieving pain of over 3 million fissures worldwide since launch.³

Adverse Events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/
Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

CHRONIC ANAL FISSURE

^{Provided by}
KKI NewCo (known as Grünenthal Meds)

RECTOGESIC^® 4 mg/g Rectal Ointment is indicated in adults for relief of pain associated with chronic anal fissure.³

Click here for prescribing and adverse event reporting information.

How useful was this page to you?

Average:

References

1. British National Formulary Online. Available at: https://bnf.nice.org.uk/treatment-summary/anal-fissure.html/ Last accessed: March 2024.

2. RECTOGESIC SmPC (UK) – Revised February 2024.

3. Kyowa Kirin Data on File - DOF-UK-073-Rectogesic.

M-RCG-UK-11-23-0004 March 2024